Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

Changes in the neutrophil count. by Lu Yang (30847)

Subjects:

Rate of chemotherapy delay and interruption of radiotherapy during concurrent chemoradiotherapy. by Lu Yang (30847)

Subjects:

Incidence of oral mucositis during concurrent chemoradiotherapy. by Lu Yang (30847)

Subjects:

Changes in the platelet count. by Lu Yang (30847)

Subjects:

Changes in the white blood cell count. by Lu Yang (30847)

Subjects:

Changes in the hemoglobin. by Lu Yang (30847)

Subjects:

WBC and ANC on day 7 post-chemotherapy. by Lu Yang (30847)

Subjects:

Incidence of grade 3 neutropenia during concurrent chemoradiotherapy. by Lu Yang (30847)

Subjects:

Repeated measures analysis of variance (RM-ANOVA) of ANC changes between experimental and control groups during concurrent chemoradiotherapy. by Lu Yang (30847)

Subjects:

General clinical data of 88 patients with NPC. by Lu Yang (30847)

Subjects:

CONSORT participant flow diagram. by Lu Yang (30847)

Subjects:

S4 File - by Lu Yang (30847)

Subjects:

S1 Data. Bibliometric analysis. S2 Data. Estrogen level analysis. S3 Data. MicroCT quantification. S4 Data. Markers of bone metabolism. by Yan She (8639796)

Skin marks is the S1 Fig title. by Mercedes Soto-González (20422078)

The significant decrease in GLT-1 levels observed in the nucleus accumbens of rats that had consumed morphine for fifty-six days was completely reversed by the co-administration of... by María Elena Quintanilla (8068691)

Image 2_Computed tomography and magnetic resonance imaging features of primary liver perivascular epithelioid cell tumor with renal angiomyolipoma: a case report and literature rev... by Ruoling Gao (12201178)

“…The enhancement slightly decreased in the equilibrium phase and the delayed phase. …”

Image 1_Computed tomography and magnetic resonance imaging features of primary liver perivascular epithelioid cell tumor with renal angiomyolipoma: a case report and literature rev... by Ruoling Gao (12201178)

“…The enhancement slightly decreased in the equilibrium phase and the delayed phase. …”

Data Sheet 1_Empagliflozin’s cardioenergetic protective effects through PPARα pathway modulation in heart failure.pdf by Hua Wei (60877)

“…Post-treatment, MRGlu and glucose uptake decreased markedly in the empagliflozin (EMPG) group, while no significant changes were observed in the fenofibrate (FF) group. …”

Summary of studies identified in the literature search, including studies excluded from the analysis and reasons for exclusion. by Junyin Pan (20700411)